Healthcare analysts provide insight into Relypsa Inc (NASDAQ:RLYP) and Aduro BioTech Inc (NASDAQ:ADRO) as Relypsa begins commercialization of Veltassa, a drug to treat hyperkalemia, …
Rosetta Resources Inc. (NASDAQ:ROSE) shares increased more than 35% in Monday pre-market trading to $26.
Aduro BioTech Inc’s (NASDAQ:ADRO) long awaited public debut has arrived. As expected, the hype for immunotherapies spilled over to Aduro as the company …
Aduro Bio Tech Inc (NASDAQ:ADRO) begins trading on Wednesday morning at 10:25 ET having completed a $119 million IPO that values the immunotherapy …
